BackComera Life Sciences Holdings- Warrants (19/05/2027) Overview

Comera Life Sciences Holdings- Warrants (19/05/2027) Total Liabilities

Latest total liabilities for CMRAW: $7.3M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$7.29M
12.82% YoYΔ $-1.07M vs prior year quarter

Peer average

Loading

Comera Life Sciences Holdings- Warrants (19/05/2027) Total Liabilities History

Loading

Comera Life Sciences Holdings- Warrants (19/05/2027) vs. peers: Total Liabilities Comparison

Loading

Comera Life Sciences Holdings- Warrants (19/05/2027) Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Comera Life Sciences Holdings- Warrants (19/05/2027) (CMRAW) FAQ

Comera Life Sciences Holdings- Warrants (19/05/2027) (CMRAW) currently reports a total liabilities of $7.3M as of September 2023. That compares with $8.4M in the prior-year period — down 12.8% year over year. Use the charts on this page to explore Comera Life Sciences Holdings- Warrants (19/05/2027)'s total liabilities history and peer comparisons.

Comera Life Sciences Holdings- Warrants (19/05/2027)'s total liabilities decreased from $8.4M to $7.3M — a 12.8% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Comera Life Sciences Holdings- Warrants (19/05/2027) reported $7.3M in total liabilities as of September 2023. That compares with $8.4M in the prior-year period — down 12.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $7.3M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Comera Life Sciences Holdings- Warrants (19/05/2027), and consider following CMRAW for alerts when major investors trade the stock.